IXICO: share price undervalues the prospects

Ixico (LSE: IXI) closed at 7.75p with a market cap of £16.97m and has today updated its trading update for the FY to September 2026, with the announcement due in early December. Revenues are expected to rise 27.8% to £8.3m, beating market expectations for the second time this year after analysis orders accelerated in the final quarter. The Company’s growth is driven by the neuroscience market, with increasing demand for its specialist neuroimaging and biomarker analytics capabilities, and by executing its Innovate, Lead, Scale strategy to maximise its ability to capture the market opportunity....

Latest News

More Articles Like This